Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1.
Gafvelin G, Thunberg S, Kronqvist M, Grönlund H, Grönneberg R, Troye-Blomberg M, Akdis M, Fiebig H, Purohit A, Horak F, Reisinger J, Niederberger V, Akdis CA, Cromwell O, Pauli G, Valenta R, van Hage M. Gafvelin G, et al. Among authors: niederberger v. Int Arch Allergy Immunol. 2005 Sep;138(1):59-66. doi: 10.1159/000087358. Epub 2005 Aug 11. Int Arch Allergy Immunol. 2005. PMID: 16103688 Clinical Trial.
Genetically modified allergens.
Niederberger V, Valenta R. Niederberger V, et al. Immunol Allergy Clin North Am. 2004 Nov;24(4):727-38. doi: 10.1016/j.iac.2004.06.009. Immunol Allergy Clin North Am. 2004. PMID: 15474868 Review.
Recombinant allergens for immunotherapy.
Valenta R, Niederberger V. Valenta R, et al. Among authors: niederberger v. J Allergy Clin Immunol. 2007 Apr;119(4):826-30. doi: 10.1016/j.jaci.2007.01.025. Epub 2007 Mar 1. J Allergy Clin Immunol. 2007. PMID: 17335886 Review.
Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season.
van Hage-Hamsten M, Kronqvist M, Zetterström O, Johansson E, Niederberger V, Vrtala S, Grönlund H, Grönneberg R, Valenta R. van Hage-Hamsten M, et al. Among authors: niederberger v. J Allergy Clin Immunol. 1999 Nov;104(5):969-77. doi: 10.1016/s0091-6749(99)70077-1. J Allergy Clin Immunol. 1999. PMID: 10550741
Recombinant allergens for immunotherapy. Where do we stand?
Niederberger V, Valenta R. Niederberger V, et al. Curr Opin Allergy Clin Immunol. 2004 Dec;4(6):549-54. doi: 10.1097/00130832-200412000-00013. Curr Opin Allergy Clin Immunol. 2004. PMID: 15640698 Review.
89 results